These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32684068)

  • 1. Inhibitory activities of indolizine derivatives: a patent review.
    Dawood KM; Abbas AA
    Expert Opin Ther Pat; 2020 Sep; 30(9):695-714. PubMed ID: 32684068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Action of Indolizines as Biologically Active Moieties: A Molecular Dynamics Study.
    Szefler B; Czelen P; Diudea MV
    Curr Comput Aided Drug Des; 2017; 13(1):22-29. PubMed ID: 27719631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory activities of bipyrazoles: a patent review.
    Abbas AA; Abdellattif MH; Dawood KM
    Expert Opin Ther Pat; 2022 Jan; 32(1):63-87. PubMed ID: 34232805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in synthesis and bioactivity studies of indolizines.
    Singh GS; Mmatli EE
    Eur J Med Chem; 2011 Nov; 46(11):5237-57. PubMed ID: 21937153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities.
    Attalah KM; Abdalla AN; Aslam A; Ahmed M; Abourehab MAS; ElSawy NA; Gouda AM
    Bioorg Chem; 2020 Jan; 94():103371. PubMed ID: 31708230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on benzofuran inhibitors: a patent review.
    Dawood KM
    Expert Opin Ther Pat; 2019 Nov; 29(11):841-870. PubMed ID: 31560232
    [No Abstract]   [Full Text] [Related]  

  • 7. Thiadiazole inhibitors: a patent review.
    Dawood KM; Farghaly TA
    Expert Opin Ther Pat; 2017 Apr; 27(4):477-505. PubMed ID: 27976971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
    Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
    J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
    Xue Y; Tang J; Ma X; Li Q; Xie B; Hao Y; Jin H; Wang K; Zhang G; Zhang L; Zhang L
    Eur J Med Chem; 2016 Jun; 115():94-108. PubMed ID: 26994846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzofuran derivatives: a patent review.
    Dawood KM
    Expert Opin Ther Pat; 2013 Sep; 23(9):1133-56. PubMed ID: 23683135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
    Venugopala KN; Chandrashekharappa S; Deb PK; Tratrat C; Pillay M; Chopra D; Al-Shar'i NA; Hourani W; Dahabiyeh LA; Borah P; Nagdeve RD; Nayak SK; Padmashali B; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Haroun M; Shashikanth S; Mohanlall V; Mailavaram R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1472-1487. PubMed ID: 34210233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacterial activity of 1-substituted indolizines.
    Gundersen LL; Negussie AH; Rise F; ØStby OB
    Arch Pharm (Weinheim); 2003 Jun; 336(3):191-5. PubMed ID: 12822185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation.
    Danac R; Al Matarneh CM; Shova S; Daniloaia T; Balan M; Mangalagiu II
    Bioorg Med Chem; 2015 May; 23(10):2318-27. PubMed ID: 25882524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII
    Olaru AM; Vasilache V; Danac R; Mangalagiu II
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1291-1298. PubMed ID: 29072097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents.
    Boot A; Brito A; VAN Wezel T; Morreau H; Costa M; Proença F
    Anticancer Res; 2014 Apr; 34(4):1673-7. PubMed ID: 24692696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
    Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Substituted indolizine-1-carbonitrile derivatives as phosphatase inhibitors.
    Weide T; Arve L; Prinz H; Waldmann H; Kessler H
    Bioorg Med Chem Lett; 2006 Jan; 16(1):59-63. PubMed ID: 16236508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug likeness, targets, molecular docking and ADMET studies for some indolizine derivatives.
    Belal A
    Pharmazie; 2018 Nov; 73(11):635-642. PubMed ID: 30396381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
    Park S; Kim EH; Kim J; Kim SH; Kim I
    Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.